Eosinophilic fasciitis responsive to treatment with pulsed steroids and cyclosporine

International Journal of Dermatology

Volumn 38, Issue 5, 1999, Pages 367-372

  Valencia, Isabel C ^a   Chang, Attica ^a   Kirsner, Robert S ^a   Kerdel, Francisco A ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Dept of Dermatol and Cutaneous S ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; METHYLPREDNISOLONE; STEROID;

ADULT; ARTICLE; CASE REPORT; DRUG RESPONSE; EOSINOPHILIC FASCIITIS; FEMALE; HUMAN; HYPERPIGMENTATION; JOINT MOBILITY; SKIN BIOPSY;

EID: 0033063305     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1999.00695.x     Document Type: Article

References (19)

1. Shulman LE. Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome? J Rheumatol 1974; 11: 569-570.
2. Varga J, Kahari VM. Eosinophilia-myalgia syndrome, eosinophilic fasciitis, and related fibrosing disorders. Curr Opin Rheumatol 1997; 9: 562-570.
3. Nassonova VA, Ivanova MM, Akhnazarova V, et al. Eosinophilic fasciitis. Review and report of six cases. Scand J Rheumatol 1979; 8: 235-233.
4. Lakhanpal S, Ginsburg WW, Michet CJ, et al. Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 1988; 17: 221-231.
5. Helfman T, Falanga V. Eosinophilic fasciitis. Clin Dermatol 1994; 12: 449-455.
6. Britto F. Patients with eosinophilic fasciitis should have a bone marrow examination to identify myelodysplasia. Br J Dermatol 1997; 137: 316-317.
7. Britt WJ, Duray PH, Dahl MN, et al. Diffuse fasciitis with eosinophilia: a steroid responsive variant of scleroderma. J Pediatr 1980; 97: 432.
8. Don IJ, Khettry U, Canoso JJ. Progressive systemic sclerosis with eosinophilia and a fulminating course. Am J Med 1978; 65: 346-348.
9. Barnes L, Rodnan GP, Medsger TA Jr, et al. Eosinophilic fasciitis. A pathologic study of twenty cases. Am J Pathol 1979; 96: 493-507.
10. King DF, Dore RK, Gilbert DJ, et al. Generalized morphea with peripheral eosinophilia, fasciitis and myositis. Int J Dermatol 1980; 19: 149-153.
11. Kahari L, Jiminez S. Increased expression of transforming growth factor-betar, fibronectin, and types I, III, and IV collagen genes in fascial fibroblasts from patients with diffuse fasciitis with eosinophilia. J Rheumatol 1996; 23: 482-486.
12. Igarashi A, Nashiro K, Kikucchi K, et al. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid and other fibrotic disorders. J Invest Dermatol 1996; 106: 729-733.
13. Blauvelt A, Falanga V. Idiopathic and L-tryptophan associated eosinophilic fasciitis before and after L-tryptophan contamination. Arch Dermatol 1991; 127: 1159-1166.
14. Granter SR, Barnhill RL, Duray PH. Borrelia fasciitis: diffuse fasciitis and peripheral eosinophilia associated with Borrelia infection. Am J Dermatopathol 1996; 18: 465-473.
15. Claw DJ, Crofford LJ. Eosinophilic rheumatic disorders. Rheum Clinics North Am 1995; 21: 231-246.
16. Fleming CJ, Clarke P, Kemmet D. Eosinophilic fasciitis with myelodysplasia responsive to treatment with cyclosporine. Br J Dermatol 1997; 136: 297-299 (letter).
17. Worl B, Hein R, Krieg T, Meurer M. Cyclosporine in localized and systemic scleroderma - a clinical study. Dermatologica 1990; 181: 215-220.
18. Zachariae H, Zachariae E. Cyclosporine A in systemic sclerosis. Br J Dermatol 1987; 116: 741-742.
19. Lohi J, Kaharai VM, Keski OJ. Cyclosporin A enhances cytokine and phorbol ester-induced fibroblast collagenase expression. J Invest Dermatol 1994; 102: 938-944.